651P Impact of abiraterone acetate plus prednisone (AAP) in patients with castration-sensitive prostate cancer (mCSPC) and visceral metastases: Subgroup analyses of the LATITUDE study

Authors :: Giulia Baciarello
Mustafa Ozguroglu
Suneel Mundle
Peter Hu
U. Richarz
G. Leitz
Kim N. Chi
Karim Fizazi
Source :: Annals of Oncology. 31:S530-S531
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: medicine.medical_specialty
business.industry
Urology
Abiraterone acetate
Hematology
Castration-sensitive prostate cancer
chemistry.chemical_compound
Oncology
chemistry
Prednisone
Medicine
In patient
business
medicine.drug

Full Text Access

Tools